| Phase 3 |
| NCT04569448 |
Brexpiprazole Treatment for Bipolar I Depression |
Bipolar Depression |
Recruiting |
2026-08-27 |
| Phase 2 |
| NCT07213349 |
Daridorexant for Alzheimer Disease Prevention |
Alzheimer Disease (AD) |
Recruiting |
2025-12-19 |
| Not applicable |
| NCT05445180 |
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and… |
Psychotic Disorders |
Recruiting |
2026-09-15 |
| NCT07786714 |
Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at… |
Clinical High Risk for Psychosis (CHR) |
Recruiting |
2026-08-28 |
| NCT07428460 |
Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia |
Schizophrenia and Predominant Negative Symptoms |
Recruiting |
2026-08-20 |
| NCT07002996 |
Spatial Memory Training and Cognitive Function |
Mild Cognitive Impairment |
Recruiting |
2025-07-23 |
| Not specified |
| NCT06978452 |
Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental… |
Depression - Major Depressive Disorder |
Recruiting |
2025-05-18 |
| NCT06978803 |
HYEEG Discourse in Psychosis: A Neurobehavioural Study |
Psychosis |
Recruiting |
2025-05-18 |
| NCT06978894 |
Predicting Psychotic Relapse Using Speech-Based Early Detection |
Psychosis |
Recruiting |
2025-05-18 |
| NCT06978465 |
DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in Psychosis |
Psychosis |
Not Yet Recruiting |
2025-05-18 |
| NCT06978881 |
Magnetoencephalography in Psychosis Program |
Schizophrenia Disorders |
Enrolling by Invitation |
2025-05-18 |